Merck Unveils New RSV Shot for Babies, as Moderna Trials mRNA RSV Vaccine for Infants and Toddlers
As the market for RSV shots booms, Merck announced a new monoclonal antibody shot with “positive” results in infants, while Moderna called for more participants in its mRNA RSV vaccine trial by posting on Instagram a picture of the first baby to receive the experimental vaccine.
